CVS Health plans to split into two publicly traded companies by the first half of 2028, according to CNBC. One company would hold its pharmacy business, including roughly 9,000 retail locations. The other would hold its insurance business, Aetna, and its pharmacy benefit manager, Caremark.
CVS CEO David Joyner told CNBC's "Squawk on the Street" that in 2024 the company was "in a turnaround" and lacked the flexibility, cash or performance to execute a split. He said the company now can make the decision "out of strength." CVS has posted eight consecutive quarters of beating Wall Street earnings estimates, and it has raised its guidance several times over the last two years.
Analysts quoted in the report say the economics of the businesses have changed. Brian Tanquilut of Jefferies said, "Back then, the idea of retail standing alone was unthinkable." Michael Cherny of Leerink Partners said the pharmacy "is a much different business" than it was in prior years. The report says the retail pharmacy has become more consistently profitable, partly because of store closures by Walgreens and Rite Aid and changes to CVS's reimbursement model.
The retail pharmacy segment remains low-margin, with adjusted operating margins of roughly 4% to 5%, according to the report. Analysts say investors may value it at a discount to CVS's other businesses.
CVS's shares fell about 12% after the announcement, according to the report. Caremark also faces state-level lawsuits and regulatory challenges over pharmacy benefit manager practices. Joyner told the Wall Street Journal that the split is not driven by regulatory issues. CVS says the separation follows a strategic review.